tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Zevra Therapeutics: Strong Buy Rating Amid U.S. Growth and EU Market Potential
PremiumRatingsZevra Therapeutics: Strong Buy Rating Amid U.S. Growth and EU Market Potential
16d ago
Zevra Therapeutics price target lowered to $18 from $19 at Citizens JMP
Premium
The Fly
Zevra Therapeutics price target lowered to $18 from $19 at Citizens JMP
16d ago
Zevra Therapeutics Reports Strong Q2 2025 Results
Premium
Company Announcements
Zevra Therapeutics Reports Strong Q2 2025 Results
16d ago
Zevra Therapeutics: Buy Rating Affirmed on European Market Expansion and Growth Potential
PremiumRatingsZevra Therapeutics: Buy Rating Affirmed on European Market Expansion and Growth Potential
1M ago
Zevra Therapeutics submits MAA to EMA for evaluation of arimoclomol
Premium
The Fly
Zevra Therapeutics submits MAA to EMA for evaluation of arimoclomol
1M ago
Zevra Therapeutics announces MIPLYFFA , OLPRUVA presentations at SERGG
Premium
The Fly
Zevra Therapeutics announces MIPLYFFA , OLPRUVA presentations at SERGG
1M ago
Zevra Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe FlyZevra Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
Zevra Therapeutics Elects New Directors at Annual Meeting
Premium
Company Announcements
Zevra Therapeutics Elects New Directors at Annual Meeting
3M ago
Zevra announces 3 proxy advisory firms recommended vote ‘FOR’ Dixon, Favorito
Premium
The Fly
Zevra announces 3 proxy advisory firms recommended vote ‘FOR’ Dixon, Favorito
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100